Researchers identified a strong association between GLP-1 medications and reduced rates of multiple substance use disorders, raising new questions about how these drugs may affect the brain’s reward system. What if some of the world’s most popular weight loss drugs are affecting more than appetite? A new study suggests that GLP-1 medications, a class of [...]from SciTechDaily https://ift.tt/sE90pcw